Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
2.
Mucosal Immunol ; 11(2): 474-485, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-28766554

RESUMEN

Campylobacter jejuni is the most prevalent cause of foodborne bacterial enteritis worldwide. Patients present with diarrhea and immune responses lead to complications like arthritis and irritable bowel syndrome. Although studies exist in animal and cell models, we aimed at a functional and structural characterization of intestinal dysfunction and the involved regulatory mechanisms in human colon. First, in patients' colonic biopsies, sodium malabsorption was identified as an important diarrheal mechanism resulting from hampered epithelial ion transport via impaired epithelial sodium channel (ENaC) ß- and γ-subunit. In addition, barrier dysfunction from disrupted epithelial tight junction proteins (claudin-1, -3, -4, -5, and -8), epithelial apoptosis, and appearance of lesions was detected, which cause leak-flux diarrhea and can perpetuate immune responses. Importantly, these effects in human biopsies either represent direct action of Campylobacter jejuni (ENaC impairment) or are caused by proinflammatory signaling (barrier dysfunction). This was revealed by regulator analysis from RNA-sequencing (cytometric bead array-checked) and confirmed in cell models, which identified interferon-γ, TNFα, IL-13, and IL-1ß. Finally, bioinformatics' predictions yielded additional information on protective influences like vitamin D, which was confirmed in cell models. Thus, these are candidates for intervention strategies against C. jejuni infection and post-infectious sequelae, which result from the permissive barrier defect along the leaky gut.


Asunto(s)
Infecciones por Campylobacter/inmunología , Campylobacter jejuni/fisiología , Colon/inmunología , Enteritis/inmunología , Mucosa Intestinal/metabolismo , Síndromes de Malabsorción/inmunología , Sodio/metabolismo , Adulto , Apoptosis , Células Cultivadas , Colon/microbiología , Biología Computacional , Citocinas/genética , Citocinas/metabolismo , Enteritis/microbiología , Canales Epiteliales de Sodio/metabolismo , Femenino , Humanos , Mediadores de Inflamación/metabolismo , Mucosa Intestinal/patología , Transporte Iónico , Síndromes de Malabsorción/microbiología , Masculino , Persona de Mediana Edad , Transducción de Señal , Proteínas de Uniones Estrechas/metabolismo , Vitamina D/metabolismo
3.
Mucosal Immunol ; 7(2): 369-78, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23900194

RESUMEN

The probiotic Escherichia coli Nissle 1917 (EcN) is widely used to maintain remission in ulcerative colitis. This is thought to be mediated by various immunomodulatory and barrier-stabilizing effects in the intestine. In this study, the mechanisms of barrier modulation by EcN were studied in the human epithelial HT-29/B6 cell culture model.EcN supernatant increased transepithelial resistance (TER) and reduced permeability to mannitol because of sealing of the paracellular passage pathway as revealed by two-path impedance spectroscopy. This increase in TER was attributed to the TcpC protein of EcN. TcpC induced protein kinase C-ζ (PKCζ) and extracellular-signal-regulated kinase 1/2 (ERK1/2) phosphorylation, which in turn resulted in upregulation of the barrier-forming tight junction protein claudin-14. By specific silencing of protein expression by small interfering RNA (siRNA), the sealing function of claudin-14 was confirmed. In conclusion, the TcpC protein of EcN affects innate immunity by improving intestinal barrier function through upregulation of claudin-14 via PKCζ and ERK1/2 signaling.


Asunto(s)
Proteínas de Escherichia coli/metabolismo , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Membrana Mucosa/inmunología , Membrana Mucosa/metabolismo , Proteína Quinasa C/metabolismo , Factores de Virulencia/metabolismo , Animales , Animales Recién Nacidos , Línea Celular , Claudinas/metabolismo , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Escherichia coli/metabolismo , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/farmacología , Técnicas de Inactivación de Genes , Células HT29 , Humanos , Membrana Mucosa/efectos de los fármacos , Permeabilidad , Fosforilación/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Porcinos , Factores de Virulencia/genética , Factores de Virulencia/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA